Calcium Hydroxylapatite Injection
Ingredient: 26mg/ml HA, Hydroxyapatite 30%
Specification: 1ml
Package: Single package
Application Area: Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc.
Product Introduction:
With a high content of sodium hyaluronate, the product ensures an instant lift and natural appearance right from the initial injection. Moreover, the hydroxyapatite microspheres feature a high surface porosity, offering an increased interaction area with fibroblasts. This promotes better protein and cell attachment, enhancing the concentration of self-growth factors.
Product Display:
Product Details:
Type | |
Ingredient | Hyaluronic 26mg/ml, hydroxyapatite 30% |
Specification | 1ml |
Effect area | Subcutaneous injection |
Application area | Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12-24 months |
Lasting time | 18-24 months |
Microsphere size | 25-45μm |
Extruding force | 23N (27G thin-walled needle) |
Product Package:
Customer Feedback:
Raw Material Advantages:
1. Sodium hyaluronate deeply infuses the dermis, quickly revitalizing the skin and providing an instant lifting and firming effect. Meanwhile, hydroxyapatite stimulates the proliferation of collagen fibers, effectively repairing the skin’s internal structure and promoting natural collagen regeneration. Over time, a refined and firm collagen structure forms, delivering long-lasting lifting benefits.
2. Compared to leading American brands, our product boasts a higher sodium hyaluronate concentration of 24-26mg/ml, achieving an instant firm and natural appearance post-injection. Furthermore, the hydroxyapatite in our product contains microspheres with a high surface porosity, increasing their interaction with fibroblasts. This improves protein and cell adhesion, boosting the chances of self-growth factor accumulation.
Development Process:
Company Introduction:
Ensuring low tin content (Sn <30 ppm), controlled molecular weight, and medical-grade biocompatibility, our PCL/PLLA synthesis process is carried out using custom-designed synthesis equipment under anhydrous, oxygen-free conditions at kilogram-scale production capacity. Simultaneously, our purification platform processes industrial-grade raw materials to yield sterile, pyrogen-free medical-grade substances, including but not limited to sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.